Silverback Therapeutics Inc (SBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SBTX | TRVI | MOLN | ||
| Company | Silverback Therapeutics Inc | Trevi Therapeutics Inc | Molecular Partners Ag ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.82 | 2.77 | 5.48 | ||
| High | 6.15 | 2.83 | 5.48 | ||
| Low | 5.72 | 2.73 | 5.16 | ||
| Last | 5.87 | 2.73 | 5.42 | ||
| Change | +0.06 | -0.04 | +0.22 | ||
| % Change | +1.03% | -1.44% | +4.23% | ||
| Volume | 116,700 | 139,800 | 11,600 | ||
| 20-Day Average Volume | 195,280 | 519,495 | 17,460 | ||
| Previous Close | 5.81 | 2.77 | 5.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.79 | 2.96 | 5.83 | ||
| 20-Day Raw Stochastic | 60.38% | 9.68% | 17.32% | ||
| 20-Day Relative Strength | 54.62% | 42.41% | 48.15% | ||
| Weighted Alpha | -17.00 | +45.91 | -30.14 | ||
| Today's Opinion | 100% Buy | 24% Sell | 8% Buy | ||
| Previous Opinion | 100% Buy | 24% Sell | 24% Sell | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.55% since 11/01/22 | -4.55% since 11/14/24 | +3.24% since 11/14/24 | ||
| Low | 5.72 on 11/08/22 | 2.67 on 11/15/24 | 5.11 on 11/15/24 | ||
| High | 6.46 on 11/02/22 | 3.07 on 11/19/24 | 6.14 on 11/19/24 | ||
| 1-Month | |||||
| %Chg | +11.81% since 10/07/22 | -18.51% since 10/21/24 | -20.06% since 10/21/24 | ||
| Low | 4.91 on 10/13/22 | 2.67 on 11/15/24 | 5.11 on 11/15/24 | ||
| High | 6.50 on 10/31/22 | 3.40 on 10/22/24 | 7.60 on 10/22/24 | ||
| 3-Month | |||||
| %Chg | +17.87% since 08/08/22 | -2.85% since 08/21/24 | -14.31% since 08/21/24 | ||
| Low | 4.45 on 09/23/22 | 2.67 on 11/15/24 | 4.37 on 10/02/24 | ||
| High | 6.50 on 10/31/22 | 3.69 on 09/17/24 | 7.60 on 10/22/24 | ||
| 6-Month | |||||
| %Chg | +94.37% since 05/06/22 | unch since 05/21/24 | +51.40% since 05/21/24 | ||
| Low | 2.80 on 05/12/22 | 2.30 on 06/10/24 | 3.60 on 05/31/24 | ||
| High | 6.50 on 10/31/22 | 3.69 on 09/17/24 | 12.70 on 06/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 211,660 | 212,919 | 209,748 | ||
| Shares Outstanding, K | 36,058 | 76,866 | 40,337 | ||
| Annual Sales | 0 | 0 | 7,840,000 | ||
| Annual Net Income | -89,480,000 | -29,070,000 | -69,040,000 | ||
| Last Quarter Sales | 0 | 0 | 790,000 | ||
| Last Quarter Net Income | -17,860,000 | -13,240,000 | -18,950,000 | ||
| 60-Month Beta | 0.60 | 1.01 | 0.98 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 11/02/22 | -0.13 on 11/06/24 | -0.57 on 10/31/24 | ||
| Latest Earnings Date | 11/09/22 | 11/06/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||